Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion.
Vitamin D status and ill health: a systematic review.
Social cognition in pediatric-onset multiple sclerosis (MS).
Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
A genome-wide association study in progressive multiple sclerosis.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Disclosing the diagnosis of multiple sclerosis: The Profile Project.
Neurorehabilitation for other neurologic disorders.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
A culture system to study oligodendrocyte myelination processes using engineered nanofibers.
Substance Name: Riluzole
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells.
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Accelerometer output and its association with energy expenditure in persons with multiple sclerosis.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
Pharmacology of HIV integrase inhibitors.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
Pages
« first
‹ previous
…
199
200
201
202
203
204
205
206
207
…
next ›
last »